台灣南部某職場工作者低密度脂蛋白膽固醇過高之盛行率及相關因子探討

Prevalence of Elevated Low-density Lipoprotein Cholesterol among Young Workers at a Factory in Southern Taiwan

10.7023/TJFM.200812.0221

林志遠(Chih-Yuan Lin)；王建楠(Jian-Nan Wang)；蘇世斌(Shih-Bin Su)

LDL-C ； dyslipidemia ； cardiovascular disease

台灣家庭醫學雜誌

18卷4期（2008 / 12 / 01）

221 - 232

繁體中文

Purpose: Dyslipidemia and elevated low-density lipoprotein cholesterol (LDL-C) have been identified as risk factors for atherosclerosis and cardiovascular disease. The aim of this study was to evaluate the prevalence of and factors related to elevated LDL-C among young workers in southern Taiwan. Materials & Methods: We conducted a cross-sectional study by analyzing the database from the 2007 annual health examination of a company in southern Taiwan. Anthropometric measurements, sex, age, serum lipid profile, blood pressure, glutamic-pyruvic transaminase (GPT), and fasting glucose were recorded. Patients were divided into 4 categories according to their level of LDL-C: ＜130 mg/dL, 130-159 mg/dL, 160-189 mg/dL, ＞190 mg/dL; and elevated LDL-C was defined ＞130 mg/dL. Result: A total of 16,123 workers, 7,556 (46.9%) men and 8,567 (53.1%) women, were recruited. The mean serum level of LDL-C in the men (115.6±29.4 mg/dL) was higher than that in the women (104.1±27.0 mg/dL) ( p＜0.001). The overall prevalence of elevated LDL-C was 21.3%. The older men with higher BMI and blood pressure, and abnormal fasting glucose, GPT, triacylglycerol (TG), and high-density lipoprotein cholesterol (HDL-C) had a higher prevalence of elevated LDL-C. After adjusting for age, sex, BMI, blood pressure, fasting glucose, GPT, TG, and HDL-C, male sex, older age, higher BMI, higher blood pressure, impaired fasting glucose, and abnormal GPT, TG, and HDL-C were independent risk factors of elevated LDL-C. Conclusion: Elevated LDL-C was prevalent, and its risk factors were similar to those for cardiovascular disease in this young working population.

Purpose: Dyslipidemia and elevated low-density lipoprotein cholesterol (LDL-C) have been identified as risk factors for atherosclerosis and cardiovascular disease. The aim of this study was to evaluate the prevalence of and factors related to elevated LDL-C among young workers in southern Taiwan. Materials & Methods: We conducted a cross-sectional study by analyzing the database from the 2007 annual health examination of a company in southern Taiwan. Anthropometric measurements, sex, age, serum lipid profile, blood pressure, glutamic-pyruvic transaminase (GPT), and fasting glucose were recorded. Patients were divided into 4 categories according to their level of LDL-C: ＜130 mg/dL, 130-159 mg/dL, 160-189 mg/dL, ＞190 mg/dL; and elevated LDL-C was defined ＞130 mg/dL. Result: A total of 16,123 workers, 7,556 (46.9%) men and 8,567 (53.1%) women, were recruited. The mean serum level of LDL-C in the men (115.6±29.4 mg/dL) was higher than that in the women (104.1±27.0 mg/dL) ( p＜0.001). The overall prevalence of elevated LDL-C was 21.3%. The older men with higher BMI and blood pressure, and abnormal fasting glucose, GPT, triacylglycerol (TG), and high-density lipoprotein cholesterol (HDL-C) had a higher prevalence of elevated LDL-C. After adjusting for age, sex, BMI, blood pressure, fasting glucose, GPT, TG, and HDL-C, male sex, older age, higher BMI, higher blood pressure, impaired fasting glucose, and abnormal GPT, TG, and HDL-C were independent risk factors of elevated LDL-C. Conclusion: Elevated LDL-C was prevalent, and its risk factors were similar to those for cardiovascular disease in this young working population.

1. Chang HY,Yeh WT,Chang YH(2002).Prevalence of dyslipidemia and mean blood lipid values in Taiwan: results from the Nutrition and Health Survey in Taiwan (NAHSIT, 1993-1996).Chin J Physiol,45,187-197.
   連結：
2. (2001).Executive Summary of the Third Report of the National Cholesterol Education Program (NCEP) Expert on Detection, Evaluation and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III).JAMA,285,2486-2497.
3. As smann G,Schulte H(1992).Relation of high-density lipoprotein cholesterol and triglycerides to incidence of atherosclerotic coronary artery disease (the PROCAM experience).Am J Cardiol,70,733-737.
4. Assmann G,Cullen P,Schulte H(1998).The Münster Heart Study (PROCAM): results of follow-up at 8 years.Eur Heart J,19,2-11.
5. Bhatnagar D,Soran H,Durrington PN(2008).Hypercholesterolaemia and its management.BMJ,337,503-508.
6. Chiena KL,Sung FC,Hsua HC(2005).Relative importance of atherosclerotic risk factors for coronary heart disease in Taiwan.Eur J Cardiovasc Prev Rehabil,12,95-101.
7. Dahlen G,Guyton JR,Attar M(1986).Association of levels of lipoprotein Lp (a), plasma lipids, and other lipoproteins with coronary artery disease documented by 162 angiography.Circulation,74,758-765.
8. Denke MA(1996).Lipids, estrogen status, and coronary heart disease risk in women.Med Sci Sports Exerc,28,13-14.
9. Donald ML,Peter WF,Martin GL(2003).Lifetime risk of coronary heart disease by cholesterol levels at selected ages.Arch Intern Med,163,1966-1972.
10. Haffner SM(1998).Management of dyslipidemia in adults with diabetes.Diabetes Care,21,160-178.
11. Kannel WB(2000).Risks tratification in hyper tens ion: new insights from the Framingham Study.Am J Hypertens,13,3-10.
12. Koletzko B,Herzog M(1998).Hyperlipidemia in children and adolescents: diagnosis and therapy.Schweiz Med Wochenschr,128,477-485.
13. Lewington S,Whitlock G,Clarke R(2007).Blood cholesterol and vascular mortality by age, sex, and blood pressure: a meta-analysis of individual data from 61 prospective studies with 55,000 vascular deaths.Lancet,370,1829-1839.
14. Li Z,Yang R,Xu G(2005).Serum lipid concentrations and prevalence of dyslipidemia in a large professional population in Beijing.Clin Chem,51,144-150.
15. Margaret DC,David AL,Paul DS(2005).Trends in serum lipids and lipoproteins of adults, 1960-2002.JAMA,294,1773-1781.
16. O`Donnell CJ,Elosua R(2008).Cardiovascular risk factors. Insights from Framingham Heart Study.Rev Esp Cardiol,61,299-310.
17. Parekh S,Anania FA(2007).Abnormal lipid and glucose metabolism in obesity: implications for nonalcoholic fatty liver disease.Gastroenterology,132,2191-2207.
18. Quiñones-Galvan A,Pucciarelli A,Fratta-Pasini A(2001).Effective blood pressure treatment improves LDL-cholesterol susceptibility to oxidation in patients with essential hypertension.J Intern Med,250,322-326.
19. Reeder BA,Angel A,Ledoux M(1992).Obesity and its relation to cardiovascular disease risk factors in Canadian adults. Canadian Heart Health Surveys Research Group.Can Med Assoc J,146,2009-2019.
20. Stamler J,Daviglus ML,Garside DB(2000).Relationship of baseline serum cholesterol levels in 3 large cohorts of younger men to long-term coronary, cardiovascular, and allcause mortality and to longevity.JAMA,284,311-318.
21. Taskinen MR(2005).Type 2 diabetes as a lipid disorder.Curr Mol Med,5,297-308.
22. Turner RC,Millns H,Neil HA(1998).Risk factors for coronary artery disease in noninsulin dependent diabetes mellitus: United Kingdom Prospective Diabetes Study (UKPDS:23).BMJ,316,823-828.
23. Zhang X,Sun Z,Zheng L(2007).Prevalence of dyslipidemia and associated factors among the hypertensive rural Chinese population.Arch Med Res,38,432-439.
24. 丁予安、何橈通、宋育民(2003)。高血脂防治手冊：國人血脂異常診療及預防指引。台北市:行政院衛生署國民健康局。
25. 台灣地區高血壓、高血糖、高血脂盛行率調查期末報告
26. 李威儒、陳亮恭、陳振文(2004)。宜蘭鄉村地區中老年人血脂肪異常盛行率與控制概況。北市醫學雜誌，1，459-467。
27. 陳妙汝、張慧如、翁千惠(2007)。臺灣中部地區高膽固醇血症之盛行率及相關因素研究－以彰化縣伸港鄉居民為例。秀傳醫學雜誌，7，7-13。